Skip to main content
Premium Trial:

Request an Annual Quote

SeqWright to Offer HairDx Test Service

NEW YORK (GenomeWeb News) – SeqWright today said that it will be the exclusive genetic testing provider for Pharmagenoma's HairDx test, which evaluates a patient's responsiveness to hair-loss treatment finasteride.

Houston-based SeqWright runs a clinical lab that offers genetic testing. The firm also offers genomics services including next-generation sequencing.

SeqWright said that the test would enable patients to determine if treatment benefit outweighs the potential side effects associated with finasteride.

Terms of the agreement were not disclosed.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.